[39] These findings support a potential clinical role for oral orforglipron as a step-down or maintenance strategy after injectable GLP-1 or dual GIP/GLP-1 receptor agonist therapy, although long-term implementation depends on labeling, access, tolerability, and comparative durability
The latter, however, has a unique need for dietitians to step in and help patients on a more personal level, equipping them with a care plan that optimizes their nutrition and health outcomes alongside weight loss goals
This can significantly impact how well you tolerate the medication and minimize side effects
American Family Physician, 106 (6), 638644
Stay Hydrated: Drink plenty of water daily to assist in flushing toxins from the body and supporting glutathiones detoxifying functions
En fibroblastos humanos telomerasa-negativos se ha observado in vitro que induce la expresin de la subunidad cataltica de la telomerasa ( hTERT ), incrementa la actividad enzimtica de la telomerasa y produce elongacin de los telmeros (PMID 12937682